512 related articles for article (PubMed ID: 1569928)
1. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.
Boulay G; Servant G; Luong TT; Escher E; Guillemette G
Mol Pharmacol; 1992 Apr; 41(4):809-15. PubMed ID: 1569928
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
Balla T; Baukal AJ; Eng S; Catt KJ
Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
[TBL] [Abstract][Full Text] [Related]
3. Cardiac angiotensin receptors: effects of selective angiotensin II receptor antagonists, DUP 753 and PD 121981, in rabbit heart.
Scott AL; Chang RS; Lotti VJ; Siegl PK
J Pharmacol Exp Ther; 1992 Jun; 261(3):931-5. PubMed ID: 1602398
[TBL] [Abstract][Full Text] [Related]
4. Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state.
Boulay G; Chrétien L; Richard DE; Guillemette G
Endocrinology; 1994 Nov; 135(5):2130-6. PubMed ID: 7956936
[TBL] [Abstract][Full Text] [Related]
5. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
Chang RS; Lotti VJ
Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387
[TBL] [Abstract][Full Text] [Related]
6. Characterization of renal angiotensin II receptors using subtype selective antagonists.
Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor subtypes in bovine and human ventricular myocardium.
Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Yamada S; Inabe K; Kimura R; Suzuki H; Hoshino T
J Pharmacol Exp Ther; 1994 Aug; 270(2):566-71. PubMed ID: 8071849
[TBL] [Abstract][Full Text] [Related]
8. Characterization of putative glomerular receptors for angiotensin II in the rainbow trout Oncorhynchus mykiss using the antagonists Losartan, PD 123177, and saralasin.
Cobb CS; Brown JA
Gen Comp Endocrinol; 1993 Oct; 92(1):123-31. PubMed ID: 8262354
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-II inhibits Na+/K+ pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production.
Hajnóczky G; Csordás G; Hunyady L; Kalapos MP; Balla T; Enyedi P; Spät A
Endocrinology; 1992 Mar; 130(3):1637-44. PubMed ID: 1311245
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
[TBL] [Abstract][Full Text] [Related]
11. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N
Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
[TBL] [Abstract][Full Text] [Related]
12. Subclasses of angiotensin II binding sites and their functional significance.
Dudley DT; Panek RL; Major TC; Lu GH; Bruns RF; Klinkefus BA; Hodges JC; Weishaar RE
Mol Pharmacol; 1990 Sep; 38(3):370-7. PubMed ID: 2402226
[TBL] [Abstract][Full Text] [Related]
13. Mapping of angiotensin II receptor subtype heterogeneity in rat brain.
Song K; Allen AM; Paxinos G; Mendelsohn FA
J Comp Neurol; 1992 Feb; 316(4):467-84. PubMed ID: 1577995
[TBL] [Abstract][Full Text] [Related]
14. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors].
Sechi LA; Sechi G; De Carli S; Griffin CA; Schambelan M; Bartoli E
Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways.
Crawford KW; Frey EA; Cote TE
Mol Pharmacol; 1992 Jan; 41(1):154-62. PubMed ID: 1310139
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of angiotensin-II receptor subtypes in cultured bovine and human adrenal fasciculata cells and PC12W cells.
Ouali R; LeBrethon MC; Saez JM
Endocrinology; 1993 Dec; 133(6):2766-72. PubMed ID: 8243303
[TBL] [Abstract][Full Text] [Related]
17. Characterization of distinct angiotensin II binding sites in rat adrenal gland and bovine cerebellum using selective nonpeptide antagonists.
Wiest SA; Rampersaud A; Zimmerman K; Steinberg MI
J Cardiovasc Pharmacol; 1991 Feb; 17(2):177-84. PubMed ID: 1709220
[TBL] [Abstract][Full Text] [Related]
18. Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor.
Pucell AG; Hodges JC; Sen I; Bumpus FM; Husain A
Endocrinology; 1991 Apr; 128(4):1947-59. PubMed ID: 1848506
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
Olins GM; Corpus VM; McMahon EG; Palomo MA; Schuh JR; Blehm DJ; Huang HC; Reitz DB; Manning RE; Blaine EH
J Pharmacol Exp Ther; 1992 Jun; 261(3):1037-43. PubMed ID: 1602371
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-responsive adrenal glomerulosa cell proteins: characterization by protease mapping, species comparison, and specific angiotensin receptor antagonists.
Elliott ME; Goodfriend TL; Ball DL; Jefcoate CR
Endocrinology; 1997 Jun; 138(6):2530-6. PubMed ID: 9165045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
